金河生物(002688.SZ):子公司牛結節性皮膚病滅活疫苗通過應急評價
格隆匯10月24日丨金河生物(002688.SZ)公佈,根據國家《獸藥管理條例》和《獸藥註冊辦法》規定,金河生物科技股份有限公司子公司金河佑本生物製品有限公司(簡稱“金河佑本”)與內蒙古自治區動物疫病預防控制中心等單位聯合開發的牛結節性皮膚病滅活疫苗(NMG株,懸浮培養)已通過農業農村部組織的應急評價。金河佑本將依據《獸藥管理條例》《獸藥產品批准文號管理辦法》規定,開展該產品臨時生產文號的申請工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.